These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11238688)

  • 21. [Ductal carcinoma in situ of the breast].
    Rueda Domínguez A; Alonso Muñoz MC; Gómez Gómez A; Ojeda González B
    Med Clin (Barc); 1993 Oct; 101(14):548-56. PubMed ID: 8231402
    [No Abstract]   [Full Text] [Related]  

  • 22. [Radiotherapy in ductal in-situ breast carcinoma effective].
    Sauer R
    Strahlenther Onkol; 1993 Oct; 169(10):624-5. PubMed ID: 8235989
    [No Abstract]   [Full Text] [Related]  

  • 23. Lower-category benign breast disease and the risk of invasive breast cancer.
    Wang J; Costantino JP; Tan-Chiu E; Wickerham DL; Paik S; Wolmark N
    J Natl Cancer Inst; 2004 Apr; 96(8):616-20. PubMed ID: 15100339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiological survey of preinvasive breast cancer.
    Vandenbroucke A; Bourdon C
    Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():3-10. PubMed ID: 8298449
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current issues in the management of breast cancer.
    Hill AD; McDermott EW; O'Higgins NJ
    Ir Med J; 1996; 89(2):46-8. PubMed ID: 8682624
    [No Abstract]   [Full Text] [Related]  

  • 26. [Ductal carcinoma in situ of the breast].
    Barth A; Köchli OR; Brenner RJ; Giuliano E; Castiglione M
    Schweiz Med Wochenschr; 1995 Jan; 125(4):103-12. PubMed ID: 7878398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk of recurrence after ductal carcinoma in situ of the breast.
    Habel LA; Daling JR; Newcomb PA; Self SG; Porter PL; Stanford JL; Seidel K; Weiss NS
    Cancer Epidemiol Biomarkers Prev; 1998 Aug; 7(8):689-96. PubMed ID: 9718221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ductal carcinoma in situ of the breast: correlation between mammographic and pathologic findings.
    Evans A; Pinder S; Wilson R; Sibbering M; Poller D; Elston C; Ellis I
    AJR Am J Roentgenol; 1994 Jun; 162(6):1307-11. PubMed ID: 8191988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer statistics: Breast cancer in situ.
    Ward EM; DeSantis CE; Lin CC; Kramer JL; Jemal A; Kohler B; Brawley OW; Gansler T
    CA Cancer J Clin; 2015; 65(6):481-95. PubMed ID: 26431342
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is breast cancer overdiagnosis also nested in pathologic misclassification?
    Colin C; Devouassoux-Shisheboran M; Sardanelli F
    Radiology; 2014 Dec; 273(3):652-5. PubMed ID: 25420166
    [No Abstract]   [Full Text] [Related]  

  • 31. Reduction mammaplasty specimens and occult breast carcinomas.
    Kakagia D; Fragia K; Grekou A; Tsoutsos D
    Eur J Surg Oncol; 2005 Feb; 31(1):19-21. PubMed ID: 15642421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral contraceptives and the risk of ductal breast carcinoma in situ.
    Claus EB; Stowe M; Carter D
    Breast Cancer Res Treat; 2003 Sep; 81(2):129-36. PubMed ID: 14572155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Conjugated linoleic acid and the risk of breast cancer.
    Chajès V; Lavillonnière F; Ferrari P; Jourdan ML; Pinault M; Maillard V; Sébédio JL; Bougnoux P
    IARC Sci Publ; 2002; 156():203-4. PubMed ID: 12484165
    [No Abstract]   [Full Text] [Related]  

  • 34. When is core breast biopsy or fine-needle aspiration not enough?
    Berg WA
    Radiology; 1996 Feb; 198(2):313-5. PubMed ID: 8596822
    [No Abstract]   [Full Text] [Related]  

  • 35. The contribution of mammography screening to breast cancer incidence trends in the United States: an updated age-period-cohort model.
    Gangnon RE; Sprague BL; Stout NK; Alagoz O; Weedon-Fekjær H; Holford TR; Trentham-Dietz A
    Cancer Epidemiol Biomarkers Prev; 2015 Jun; 24(6):905-12. PubMed ID: 25787716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk for contralateral breast cancers in a population covered by mammography: effects of family history, age at diagnosis and histology.
    Ji J; Hemminki K
    Breast Cancer Res Treat; 2007 Oct; 105(2):229-36. PubMed ID: 17115107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does the volume of ductal carcinoma in situ impact the positive margin rate in patients undergoing breast conservation for invasive breast cancer?
    Martin-Dunlap TM; Cyr AE; Al Mushawah F; Gao F; Margenthaler JA
    J Surg Res; 2013 Sep; 184(1):228-33. PubMed ID: 23688789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ.
    Tuttle TM; Jarosek S; Habermann EB; Arrington A; Abraham A; Morris TJ; Virnig BA
    J Clin Oncol; 2009 Mar; 27(9):1362-7. PubMed ID: 19224844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of herbal preparations to alleviate climacteric disorders and risk of postmenopausal breast cancer in a German case-control study.
    Obi N; Chang-Claude J; Berger J; Braendle W; Slanger T; Schmidt M; Steindorf K; Ahrens W; Flesch-Janys D
    Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2207-13. PubMed ID: 19661079
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast cancer.
    Parker BA
    Med Sect Proc; 1994; ():115-20. PubMed ID: 7659706
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.